Mergers and acquisitions rife in German health service
This article was originally published in Clinica
As the German recession shows no signs of letting up and the diagnosis related groups (DRG) system for hospital reimbursement increases its impact on the health service, a growing number of health insurance funds and hospitals are looking for partners.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.